A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma
Clinical trial NCT01185548 · TERMINATED
Trial details
- NCT number
- NCT01185548
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2010-12-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.